Synergetics USA, Inc. (SURG) Reports In-Line Q4 EPS, Sales Rose 21% Y/Y

Synergetics USA, Inc. (NASDAQ: SURG) reported Q4 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $15.8 million versus the consensus estimate of $15.85 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SurgePays Reports Q2 2026 Revenue Growth of 40.7% Year-Over-Year to $16.2 Million, Reports Positive Net Income of $1.29 Million
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c